Azole compound and medicinal use thereof

Azole compound and medicinal use thereof

7117 7 123 4 2m891085 6 s12st13141422142 The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is -COOR, -X-A-COOR(Ris H, alkyl) or tetrazolyl; R, R, Rand Rare H and the like; A is -(CH)-X- (X is -N(R)-, -C(R)(R)-, -CO- or -CO-N(R)-); B is aryl or a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Inaba, Takashi, Ikemoto, Tomoyuki, Sakata, Shohei, Maegawa, Hiroshi, Kashiwagi, Atsunori
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Inaba, Takashi
Ikemoto, Tomoyuki
Sakata, Shohei
Maegawa, Hiroshi
Kashiwagi, Atsunori
description 7117 7 123 4 2m891085 6 s12st13141422142 The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is -COOR, -X-A-COOR(Ris H, alkyl) or tetrazolyl; R, R, Rand Rare H and the like; A is -(CH)-X- (X is -N(R)-, -C(R)(R)-, -CO- or -CO-N(R)-); B is aryl or aromatic heterocyclic group; Ris H and the like; Ris -(Y)-(A)-Z (Y is -O-, -S(O)-, -N(R)-, -N(R)-CO-, -N(R)-SO-, -SO-N(R)- and the like, Ais alkylene, and Z is cycloalkyl, aryl, aromatic heterocyclic group, indanyl, piperazinyl, a prodrug thereof or a pharmaceutically acceptable salt thereof. The compound [I] of the present invention has a protein tyrosine phosphatase 1B inhibitory activity, and is useful as a therapeutic agent for diabetes, a therapeutic drug for diabetic complications or a therapeutic drug for hyperlipidemia.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07163952</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07163952</sourcerecordid><originalsourceid>FETCH-uspatents_grants_071639523</originalsourceid><addsrcrecordid>eNrjZNBwrMrPSVVIzs8tyC_NS1FIBOLc1JTM5My8xByF0uJUhZKM1KLU_DQeBta0xJziVF4ozc2g4OYa4uyhW1pckFiSmldSHJ9elAiiDMwNzYwtTY2MiVACAJx7KRI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Azole compound and medicinal use thereof</title><source>USPTO Issued Patents</source><creator>Inaba, Takashi ; Ikemoto, Tomoyuki ; Sakata, Shohei ; Maegawa, Hiroshi ; Kashiwagi, Atsunori</creator><creatorcontrib>Inaba, Takashi ; Ikemoto, Tomoyuki ; Sakata, Shohei ; Maegawa, Hiroshi ; Kashiwagi, Atsunori ; Japan Tobacco Inc</creatorcontrib><description>7117 7 123 4 2m891085 6 s12st13141422142 The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is -COOR, -X-A-COOR(Ris H, alkyl) or tetrazolyl; R, R, Rand Rare H and the like; A is -(CH)-X- (X is -N(R)-, -C(R)(R)-, -CO- or -CO-N(R)-); B is aryl or aromatic heterocyclic group; Ris H and the like; Ris -(Y)-(A)-Z (Y is -O-, -S(O)-, -N(R)-, -N(R)-CO-, -N(R)-SO-, -SO-N(R)- and the like, Ais alkylene, and Z is cycloalkyl, aryl, aromatic heterocyclic group, indanyl, piperazinyl, a prodrug thereof or a pharmaceutically acceptable salt thereof. The compound [I] of the present invention has a protein tyrosine phosphatase 1B inhibitory activity, and is useful as a therapeutic agent for diabetes, a therapeutic drug for diabetic complications or a therapeutic drug for hyperlipidemia.</description><language>eng</language><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7163952$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7163952$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Inaba, Takashi</creatorcontrib><creatorcontrib>Ikemoto, Tomoyuki</creatorcontrib><creatorcontrib>Sakata, Shohei</creatorcontrib><creatorcontrib>Maegawa, Hiroshi</creatorcontrib><creatorcontrib>Kashiwagi, Atsunori</creatorcontrib><creatorcontrib>Japan Tobacco Inc</creatorcontrib><title>Azole compound and medicinal use thereof</title><description>7117 7 123 4 2m891085 6 s12st13141422142 The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is -COOR, -X-A-COOR(Ris H, alkyl) or tetrazolyl; R, R, Rand Rare H and the like; A is -(CH)-X- (X is -N(R)-, -C(R)(R)-, -CO- or -CO-N(R)-); B is aryl or aromatic heterocyclic group; Ris H and the like; Ris -(Y)-(A)-Z (Y is -O-, -S(O)-, -N(R)-, -N(R)-CO-, -N(R)-SO-, -SO-N(R)- and the like, Ais alkylene, and Z is cycloalkyl, aryl, aromatic heterocyclic group, indanyl, piperazinyl, a prodrug thereof or a pharmaceutically acceptable salt thereof. The compound [I] of the present invention has a protein tyrosine phosphatase 1B inhibitory activity, and is useful as a therapeutic agent for diabetes, a therapeutic drug for diabetic complications or a therapeutic drug for hyperlipidemia.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNBwrMrPSVVIzs8tyC_NS1FIBOLc1JTM5My8xByF0uJUhZKM1KLU_DQeBta0xJziVF4ozc2g4OYa4uyhW1pckFiSmldSHJ9elAiiDMwNzYwtTY2MiVACAJx7KRI</recordid><startdate>20070116</startdate><enddate>20070116</enddate><creator>Inaba, Takashi</creator><creator>Ikemoto, Tomoyuki</creator><creator>Sakata, Shohei</creator><creator>Maegawa, Hiroshi</creator><creator>Kashiwagi, Atsunori</creator><scope>EFH</scope></search><sort><creationdate>20070116</creationdate><title>Azole compound and medicinal use thereof</title><author>Inaba, Takashi ; Ikemoto, Tomoyuki ; Sakata, Shohei ; Maegawa, Hiroshi ; Kashiwagi, Atsunori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_071639523</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Inaba, Takashi</creatorcontrib><creatorcontrib>Ikemoto, Tomoyuki</creatorcontrib><creatorcontrib>Sakata, Shohei</creatorcontrib><creatorcontrib>Maegawa, Hiroshi</creatorcontrib><creatorcontrib>Kashiwagi, Atsunori</creatorcontrib><creatorcontrib>Japan Tobacco Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Inaba, Takashi</au><au>Ikemoto, Tomoyuki</au><au>Sakata, Shohei</au><au>Maegawa, Hiroshi</au><au>Kashiwagi, Atsunori</au><aucorp>Japan Tobacco Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Azole compound and medicinal use thereof</title><date>2007-01-16</date><risdate>2007</risdate><abstract>7117 7 123 4 2m891085 6 s12st13141422142 The present invention relates to an azole compound represented by the formula [I] wherein W is S or O; R is -COOR, -X-A-COOR(Ris H, alkyl) or tetrazolyl; R, R, Rand Rare H and the like; A is -(CH)-X- (X is -N(R)-, -C(R)(R)-, -CO- or -CO-N(R)-); B is aryl or aromatic heterocyclic group; Ris H and the like; Ris -(Y)-(A)-Z (Y is -O-, -S(O)-, -N(R)-, -N(R)-CO-, -N(R)-SO-, -SO-N(R)- and the like, Ais alkylene, and Z is cycloalkyl, aryl, aromatic heterocyclic group, indanyl, piperazinyl, a prodrug thereof or a pharmaceutically acceptable salt thereof. The compound [I] of the present invention has a protein tyrosine phosphatase 1B inhibitory activity, and is useful as a therapeutic agent for diabetes, a therapeutic drug for diabetic complications or a therapeutic drug for hyperlipidemia.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07163952
source USPTO Issued Patents
title Azole compound and medicinal use thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A23%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Inaba,%20Takashi&rft.aucorp=Japan%20Tobacco%20Inc&rft.date=2007-01-16&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07163952%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true